Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-20-007351

President and CEO sold 15,000 shares at $45.00 ($675,000)

  • President and CEO acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-16 Exercise or conversion : show line 1 in the form +15,000 $0.85 $12,750 256,000 D
2020-12-16 Sale : show line 2 in the form −15,000 $45.00 $675,000 241,000 D
Open-market sales · 15,000 sh · avg $45.00 · $675,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-16 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −15,000 60,170 D
Loading xslF345X03/primarydocument.xml…